UK markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2150+0.0060 (+2.87%)
At close: 04:00PM EDT
0.2153 +0.00 (+0.14%)
After hours: 06:10PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
548.721
10,055
5,005
14,039
Total cash
548.721
10,055
5,005
14,039
Other current assets
839.59
2,509
2,473
1,456
Total current assets
1,591
12,565
7,477
15,496
Non-current assets
Property, plant and equipment
Net property, plant and equipment
4.933
5.664
16.109
23.431
Total non-current assets
109.683
488.47
1,280
357.569
Total assets
1,701
13,053
8,757
15,853
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
300.806
409.968
387.794
439.294
Accounts payable
-
3,682
1,981
946.33
Accrued liabilities
-
828.391
224.949
519.804
Total current liabilities
6,133
4,920
2,594
1,905
Non-current liabilities
Total non-current liabilities
0
0
0
0
Total liabilities
6,133
4,920
2,594
1,905
Stockholders' equity
Common stock
6.214
1.617
0.949
23.856
Retained earnings
-69,567
-50,716
-35,442
-20,946
Total stockholders' equity
-4,432
8,133
6,163
13,948
Total liabilities and stockholders' equity
1,701
13,053
8,757
15,853